Coverage
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology
Oncology coverage from APO|APE News.

Johnson & Johnson Turned Rybrevant's Survival Win Into a Once-a-Month Injection, With More Planned for Amivantamab

FDA Approves Jazz's Bispecific HER2 Antibody Ziihera, With and Without BeOne's Tevimbra, for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

Allegheny Health Network and The START Center for Cancer Research Will Put an Early-Phase Trial Site Inside Allegheny General Hospital

FDA Grants Fast Track Designation to Erasca's Oral Pan-RAS Molecular Glue ERAS-0015 for Metastatic Pancreatic Adenocarcinoma

Elacestrant Plus Everolimus Delivers 8.3-Month Median PFS After CDK4/6 Inhibitor Progression in the ELEVATE Umbrella Study

Lustgarten Foundation Directs $22.8 Million to 18 Pancreatic Cancer Projects, Led by KRAS Interception and Early-Detection Trials

FDA Grants Nuvation Bio's Mutant-IDH1 Inhibitor Safusidenib Fast Track Designation for IDH1-Mutant Glioma

Cerenome Pairs Reyobiq Intrathecal PK Data With a CNSide Cost-of-Care Model at the SNO/ASCO CNS Metastases Conference

AbbVie Lines Up 11 WCLC 2026 Presentations Led by an Oral on the PD-1/VEGF Bispecific ABBV-1480

Isolated Deep Submucosal Invasion Preceded Lymph Node Metastasis in 12.9 Percent of T1 Colorectal Cancers

A Tata Memorial Review Sorts KRAS Resistance Into Four Routes and Puts Next-Generation G12C Response at 45% to 55%

West Cancer Center Wins IRB Approval to Enroll in IceCure's ChoICE Breast Cryoablation Study

BioNTech Books a Late-Breaking Slot in Seoul for the First Lung Cancer Data Pairing a PD-L1xVEGF Bispecific With an ADC

Osaka Group Reports Its Accelerator BNCT Experience in About 200 Head and Neck Cancer Cases

IDEAYA and Genentech to Pair IDE892 With KRAS G12D Inhibitor in MTAP-Deleted Pancreatic Cancer

China's Clinical Oncology Society Sets 12 GRADE-Rated Recommendations for Antiangiogenic TKIs in Sarcoma

Pembrolizumab After Platinum Linked to Longer Survival in 147 Uterine Carcinosarcoma Patients

